Aimee W Smith1, Constance A Mara1, Avani C Modi2. 1. Division of Behavioral Medicine and Clinical Psychology, Cincinnati Children's Hospital Medical Center, 3333 Burnet Ave., Cincinnati, OH 45229-3039, USA. 2. Division of Behavioral Medicine and Clinical Psychology, Cincinnati Children's Hospital Medical Center, 3333 Burnet Ave., Cincinnati, OH 45229-3039, USA. Electronic address: avani.modi@cchmc.org.
Abstract
INTRODUCTION: The aims of the current study were to identify patterns and predictors of adherence in adolescents with epilepsy over one year, as well as its impact on seizures and health-related quality of life (HRQOL). METHODS: Forty-eight adolescents with epilepsy (Mage=14.8+1.5, 69% female, 73% White: NonHispanic) and their caregivers completed questionnaires assessing demographics, epilepsy knowledge, side effects, adherence barriers, family functioning, and HRQOL at quarterly clinic visits over one year. Adherence was monitored electronically via MEMS TrackCaps. Seizures were determined via chart review. RESULTS: Baseline adherence was 86.05% and significantly decreased over 12months (b=-2.07, p<0.001). Higher adherence was predicted by higher socioeconomic status (SES) (b=0.04, p<0.05), more side effects (b=0.06, p<0.01), fewer caregiver-reported adherence barriers (b=0.18, p<0.05), and lower family conflict (b=-0.19, p<0.05). Change in adherence over 12months did not significantly predict HRQOL or seizures. CONCLUSIONS: This is the first longitudinal study of objective adherence in adolescents with epilepsy. Given adolescence is a period of vulnerability during development, including declining adherence, caregivers are encouraged to continue collaborating with their adolescents around epilepsy management. Adherence barriers represent an ideal target for intervention and can be implemented in the clinic by frontline providers. Multidisciplinary care can address low SES (social work, financial advocates) and family conflict (psychologists, therapists) in patients with the ultimate goal of optimizing adherence and health outcomes.
INTRODUCTION: The aims of the current study were to identify patterns and predictors of adherence in adolescents with epilepsy over one year, as well as its impact on seizures and health-related quality of life (HRQOL). METHODS: Forty-eight adolescents with epilepsy (Mage=14.8+1.5, 69% female, 73% White: NonHispanic) and their caregivers completed questionnaires assessing demographics, epilepsy knowledge, side effects, adherence barriers, family functioning, and HRQOL at quarterly clinic visits over one year. Adherence was monitored electronically via MEMS TrackCaps. Seizures were determined via chart review. RESULTS: Baseline adherence was 86.05% and significantly decreased over 12months (b=-2.07, p<0.001). Higher adherence was predicted by higher socioeconomic status (SES) (b=0.04, p<0.05), more side effects (b=0.06, p<0.01), fewer caregiver-reported adherence barriers (b=0.18, p<0.05), and lower family conflict (b=-0.19, p<0.05). Change in adherence over 12months did not significantly predict HRQOL or seizures. CONCLUSIONS: This is the first longitudinal study of objective adherence in adolescents with epilepsy. Given adolescence is a period of vulnerability during development, including declining adherence, caregivers are encouraged to continue collaborating with their adolescents around epilepsy management. Adherence barriers represent an ideal target for intervention and can be implemented in the clinic by frontline providers. Multidisciplinary care can address low SES (social work, financial advocates) and family conflict (psychologists, therapists) in patients with the ultimate goal of optimizing adherence and health outcomes.
Authors: Cyd K Eaton; Michelle N Eakin; Shayna Coburn; Cozumel S Pruette; Tammy M Brady; Barbara A Fivush; Susan Mendley; Shamir Tuchman; Kristin A Riekert Journal: J Pediatr Psychol Date: 2019-01-01
Authors: Charles D Varnell; Kristin L Rich; Avani C Modi; David K Hooper; Mark H Eckman Journal: Am J Kidney Dis Date: 2022-02-25 Impact factor: 11.072
Authors: D H Grossoehme; E Smith; D Standiford; N Morwessel; J Kichler; D M Maahs; K Driscoll; M Seid Journal: Diabet Med Date: 2019-02-12 Impact factor: 4.359
Authors: Cyd K Eaton; Kara M Duraccio; Michelle N Eakin; Tammy M Brady; Cozumel S Pruette; Thomas Eckmann; Susan R Mendley; Shamir Tuchman; Barbara A Fivush; Kristin A Riekert Journal: Health Psychol Date: 2020-03-23 Impact factor: 4.267
Authors: Avani C Modi; Anup D Patel; Ana M Gutierrez-Colina; Sara E Wetter; Leah M Heckaman; Andrea Debs; Constance A Mara; Evelynne Wentzel; Matthew Schmidt; Jack Stevens Journal: Epilepsy Behav Date: 2020-12-09 Impact factor: 2.937
Authors: Charles D Varnell; Kristin L Rich; Bin Zhang; Adam C Carle; Ahna L H Pai; Avani C Modi; David K Hooper Journal: Pediatr Nephrol Date: 2021-01-27 Impact factor: 3.651